Carboranyl Oligonucleotides: 4. Synthesis and Physicochemical Studies of Oligonucleotides Containing 2′-O-(o-Carboran-1-yl)Methyl Group
- 1 April 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 12 (2) , 79-94
- https://doi.org/10.1089/108729002760070821
Abstract
Boronated oligonucleotides are potential candidates for antisense oligonucleotide technology (AOT), boron neutron capture therapy (BNCT), and as tools in molecular biology. A method was developed for the solid phase synthesis of oligonucleotides containing 2′-O-(o-carboran-1-yl-methyl) (2′-CBM) group. Synthesis was performed using a standard β-cyanoethyl cycle and automated DNA synthesizer. Manual steps were performed for the insertion of a modified monomer bearing the 2′-CBM group. Several tetradecanucleotides complementary to DNA-HCMV, and bearing 2′-CBM modification near the 3′-end or 5′-end or in the middle of the oligonucleotide chain were synthesized. The resulting oligomers were characterized by polyacrylamide gel electrophoresis (PAGE), reverse phase high-performance liquid chromatography (RP-HPLC), matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and ultraviolet spectroscopy (UV), circular dichroism (CD), and melting temperature (Tm) measurements. Tm of duplexes formed between 2′-CBM-modified tetradecanucleotides and complementary DNA and RNA template were compared with those formed by the unmodified oligonucleotide and complementary sequence. The stability of 2′-CBM oligonucleotides in the presence of phosphodiesterase I from Crotalus atrox venom and in human serum was studied. Oligonucleotides bearing the 2′-CBM group are characterized by increased resistance to enzymatic digestion, increased lipophilicity, and the ability to form stable duplexes with complementary templates.Keywords
This publication has 38 references indexed in Scilit:
- Carbohydrate Modifications in Antisense Oligonucleotide Therapy: New Kids on the BlockNucleosides and Nucleotides, 1999
- Impact of 3′-Exonuclease Stereoselectivity on the Kinetics of Phosphorothioate Oligonucleotide MetabolismAntisense and Nucleic Acid Drug Development, 1998
- Comparison of Physicochemical and Biological Properties of (o-Carboran-1-YL)methylphosphonate and Methylphosphonate OligonucleotidesNucleosides and Nucleotides, 1997
- THE CHEMICAL BASIS FOR DNA DIAGNOSTICS USING BORONATED DNAMain Group Metal Chemistry, 1996
- Lipid Membrane Permeability of 2′-Modified Derivatives of Phosphorothioate OligonucleotidesJournal of Pharmaceutical Sciences, 1994
- Solution-phase synthesis of boron-rich phosphatesThe Journal of Organic Chemistry, 1993
- Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy.Journal of Medicinal Chemistry, 1992
- Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cellsFEBS Letters, 1989
- Preparation and characterization of the (3)-1,2- and (3)-1,7-dicarbadodecahydroundecaborate(-1) ionsJournal of the American Chemical Society, 1968
- THE STEPWISE DEGRADATION OF THYMIDINE OLIGONUCLEOTIDES BY SNAKE VENOM AND SPLEEN PHOSPHODIESTERASESJournal of the American Chemical Society, 1958